Compare HOLX & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOLX | QXO |
|---|---|---|
| Founded | 1985 | 1988 |
| Country | United States | United States |
| Employees | N/A | 7794 |
| Industry | Medical Electronics | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 13.8B |
| IPO Year | 1995 | N/A |
| Metric | HOLX | QXO |
|---|---|---|
| Price | $76.02 | $20.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $77.89 | $32.75 |
| AVG Volume (30 Days) | ★ 8.2M | 6.9M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $4,100,500,000.00 | N/A |
| Revenue This Year | $4.74 | $70.82 |
| Revenue Next Year | $5.03 | $38.75 |
| P/E Ratio | $96.23 | ★ N/A |
| Revenue Growth | ★ 1.74 | N/A |
| 52 Week Low | $51.90 | $11.97 |
| 52 Week High | $76.07 | $27.61 |
| Indicator | HOLX | QXO |
|---|---|---|
| Relative Strength Index (RSI) | 69.09 | 51.55 |
| Support Level | $75.10 | $20.58 |
| Resistance Level | N/A | $22.25 |
| Average True Range (ATR) | 0.19 | 1.01 |
| MACD | 0.03 | 0.24 |
| Stochastic Oscillator | 95.19 | 87.54 |
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.